Showing 15,801 - 15,820 results of 121,722 for search '(( 2 e decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.25s Refine Results
  1. 15801
  2. 15802

    (a, b) The probability of failing to be matched conditioned on attractiveness <i>a</i> and degree <i>k</i> (<i>P</i><sub>not</sub>(<i>a</i>, <i>k</i>)) decreases exponentially with <i>a</i> and <i>k</i> in scale-free networks with <i>P</i>(<i>k</i>) ∼ <i>k</i><sup>−<i>γ</i></sup>, <i>γ</i> = 3 and ⟨<i>k</i>⟩ = 5. by Tao Jia (756099)

    Published 2015
    “…<p>(a, b) The probability of failing to be matched conditioned on attractiveness <i>a</i> and degree <i>k</i> (<i>P</i><sub>not</sub>(<i>a</i>, <i>k</i>)) decreases exponentially with <i>a</i> and <i>k</i> in scale-free networks with <i>P</i>(<i>k</i>) ∼ <i>k</i><sup>−<i>γ</i></sup>, <i>γ</i> = 3 and ⟨<i>k</i>⟩ = 5.…”
  3. 15803

    Regulatory B10 cells are augmented and the level of IL-10 expression is decreased in the spleen of AD mice. by Jieqiong Li (327149)

    Published 2015
    “…<p>(A) Representative dot-plots showing the percentage of CD5<sup>+</sup>CD19<sup>+</sup>CD1d<sup>hi</sup> B10 cells in control (n = 10) and AD mice (n = 10); (B) Bar graph depicting the percentage of CD5<sup>+</sup>CD19<sup>+</sup>CD1d<sup>hi</sup>B10 cells in control and AD mice as analyzed by flow cytometry. …”
  4. 15804
  5. 15805

    <b>An E115A missense variant in </b><b><i>CERS2</i></b><b> is associated with</b><b>increased sleeping energy expenditure and hepatic insulin resistance in American Indians</b> by Sascha Heinitz (8742357)

    Published 2024
    “…Association analysis of 10,084 genetic variants within 28 genes involved in sphingolipid pathways identified a missense variant (rs267738, A>C, E115A) in exon 4 of <i>CERS2</i> that was associated with higher sleeping EE (+116 kcal/day) and increased rates of endogenous glucose production during basal (+5%) and insulin-stimulated (+43%) conditions, both indicators of hepatic insulin resistance. …”
  6. 15806
  7. 15807
  8. 15808
  9. 15809
  10. 15810
  11. 15811
  12. 15812

    Ganaxolone: A Review in Epileptic Seizures Associated with Cyclin‑Dependent Kinase‑Like 5 Deficiency Disorder by Sheridan M. Hoy (4897468)

    Published 2024
    “…While somnolence and sedation are related to the dose of ganaxolone, they appear early in treatment and may decrease with continued therapy. Thus, although current evidence is somewhat limited, adjunctive ganaxolone could be a valuable therapeutic option for patients aged 2–17 years with epileptic seizures associated with CDD.…”
  13. 15813
  14. 15814
  15. 15815
  16. 15816
  17. 15817
  18. 15818
  19. 15819
  20. 15820